エストラディオールは,閉経後の骨粗鬆症において,ST3Gal1経由で骨格細胞のシアリレーションを調節する
Ce Dou1, Yang Dan2, Ziyang Zhang1
1Department of Orthopedics, Southwest Hospital, Army Medical University, Chongqing, China.
Bone research
|February 12, 2026
まとめ
更年期後のエストロゲン損失は,骨格細胞のFOS-ST3GAL1シアライレーション経路を活性化することによって,骨格喪失を加速します. シアリダゼ治療は,エストロゲン欠乏症のモデルで骨の損失を逆転させ,骨粗鬆症の治療目標を示唆しました.
科学分野:
- バイオケミストリー バイオケミストリー
- 細胞生物学 細胞生物学
- エンドクリノロジー エンドクリノロジー
背景:
- 閉経後のエストロゲン欠乏症は,骨格細胞の活性性を高めることで,骨の損失を加速させます.
- エストロゲンシグナル伝達とオステオクラストの調節を結びつける分子機構は完全に理解されていません.
研究 の 目的:
- 閉経後の骨の損失におけるRANKL誘発の骨格形成を媒介する分子経路を特定する.
- エストロゲン欠乏性骨粗鬆症におけるシアリルトランスフェラーゼST3GAL-Iの役割を調査する.
主な方法:
- ST3GAL1転写の調節におけるエストロゲン受容体α (ERα),TRAF6,c-FOSの相互作用を調査した.
- 血清シアリック酸のレベルを分析し,ヒトの骨サンプルで単細胞RNA配列を解析した.
- エストロゲン不足のマウスモデルでシアリダース治療を用いた in vivo 実験を実施した.
主要な成果:
- ST3GAL-IをRANKL誘発の骨格形成の重要な媒介体として特定した.
- エストロゲン結合のERαは,c-FOS依存のST3GAL1誘導を抑制する.
- オステオクラストの血清シアリック酸とST3GAL1発現の上昇は,閉経後の骨粗鬆症の女性で観察されました.
- シアリダゼ治療は,エストロゲン欠乏症のモデルにおける骨の損失を減少させた.
結論:
- オステオクラストにおけるエストロゲン喪失とFOS-ST3GAL1シアライレーション経路の活性化との直接的な関連が定義された.
- この経路は,閉経後の骨粗鬆症のメカニズム的な洞察を提供します.
- この経路をターゲットにすることで,骨粗鬆症に対する新しい治療戦略を提供することができる.
さらに関連する動画
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
9.8K
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
14.5K
関連する概念動画
Osteoclasts in Bone Remodeling
4.3K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.3K
Epigenetic Regulation
33.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.9K
GTPases and their Regulation
9.9K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
9.9K
Regulated Protein Degradation
8.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Master Transcription Regulators
7.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
